Jules Stolz Cand Med , Pascale Salameh PhD , Riccardo Asero MD , Emek Kocatürk MD , Jonny Peter MD, PhD , Clive Grattan MD , Leonie Shirin Herzog MD , Melba Muñoz MD, PhD , Joachim Dissemond MD , Petra Staubach-Renz MD , Andrea Bauer MD , Simon Francis Thomsen MD, PhD , Ana M. Giménez-Arnau MD , Maria Puertolas MD , Alexis Bocquet MD , Michael Makris MD, PhD , Stamatios Gregoriou MD , Maryam Khoshkhui MD , Samaneh Kouzegaran MD , Martijn Bastiaan Adriaan van Doorn MD, PhD , Manuel Pedro Pereira MD, PhD
{"title":"Parameters Linked With Higher Itch Severity in Chronic Spontaneous Urticaria—Chronic Urticaria Registry Results","authors":"Jules Stolz Cand Med , Pascale Salameh PhD , Riccardo Asero MD , Emek Kocatürk MD , Jonny Peter MD, PhD , Clive Grattan MD , Leonie Shirin Herzog MD , Melba Muñoz MD, PhD , Joachim Dissemond MD , Petra Staubach-Renz MD , Andrea Bauer MD , Simon Francis Thomsen MD, PhD , Ana M. Giménez-Arnau MD , Maria Puertolas MD , Alexis Bocquet MD , Michael Makris MD, PhD , Stamatios Gregoriou MD , Maryam Khoshkhui MD , Samaneh Kouzegaran MD , Martijn Bastiaan Adriaan van Doorn MD, PhD , Manuel Pedro Pereira MD, PhD","doi":"10.1016/j.jaip.2025.05.033","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>Itch is the most bothersome symptom in chronic spontaneous urticaria (CSU) and severely affects quality of life.</div></div><div><h3>Objective</h3><div>To analyze factors associated with itch severity, and how itch is associated with quality of life and health care use in CSU.</div></div><div><h3>Methods</h3><div>We retrieved patient data from the Chronic Urticaria Registry. Patients were categorized by self-reported itch severity (recall period of 7 days). We used ordinal logistic regressions as well as negative binomial and gamma regressions with log link to investigate possible associations.</div></div><div><h3>Results</h3><div>A total of 3,045 patients, 74.3% female, mean age 44.4 years, with no, mild, moderate, or intense itch (16.4%, 25.2%, 32.5%, and 25.9%, respectively) were included. A higher itch rating was associated with symptomatic dermographism (odds ratio [OR] = 1.25; <em>P</em> = .027), malaise (OR = 1.43; <em>P</em> < .001), depression (OR = 1.46; <em>P</em> = .008), and laboratory signs of inflammation (ie, elevated erythrocyte sedimentation rate (OR = 1.57; <em>P</em> = .031) and leukocyte counts (OR = 2.37; <em>P</em> = .004)). Intense itch was associated with worse quality of life (Chronic Urticaria Quality of Life Questionnaire; <em>P</em> < .001) and more patients visiting a general practitioner, allergologist or dermatologist, and the emergency room (<em>P</em> < .001).</div></div><div><h3>Conclusions</h3><div>Higher itch levels are associated with inflammation and depression and are linked to worse quality of life and increased health care demand. Addressing itch is crucial to reducing the humanistic and societal burden in CSU.</div></div>","PeriodicalId":51323,"journal":{"name":"Journal of Allergy and Clinical Immunology-In Practice","volume":"13 9","pages":"Pages 2349-2360.e3"},"PeriodicalIF":6.6000,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Allergy and Clinical Immunology-In Practice","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2213219825004982","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ALLERGY","Score":null,"Total":0}
引用次数: 0
Abstract
Background
Itch is the most bothersome symptom in chronic spontaneous urticaria (CSU) and severely affects quality of life.
Objective
To analyze factors associated with itch severity, and how itch is associated with quality of life and health care use in CSU.
Methods
We retrieved patient data from the Chronic Urticaria Registry. Patients were categorized by self-reported itch severity (recall period of 7 days). We used ordinal logistic regressions as well as negative binomial and gamma regressions with log link to investigate possible associations.
Results
A total of 3,045 patients, 74.3% female, mean age 44.4 years, with no, mild, moderate, or intense itch (16.4%, 25.2%, 32.5%, and 25.9%, respectively) were included. A higher itch rating was associated with symptomatic dermographism (odds ratio [OR] = 1.25; P = .027), malaise (OR = 1.43; P < .001), depression (OR = 1.46; P = .008), and laboratory signs of inflammation (ie, elevated erythrocyte sedimentation rate (OR = 1.57; P = .031) and leukocyte counts (OR = 2.37; P = .004)). Intense itch was associated with worse quality of life (Chronic Urticaria Quality of Life Questionnaire; P < .001) and more patients visiting a general practitioner, allergologist or dermatologist, and the emergency room (P < .001).
Conclusions
Higher itch levels are associated with inflammation and depression and are linked to worse quality of life and increased health care demand. Addressing itch is crucial to reducing the humanistic and societal burden in CSU.
期刊介绍:
JACI: In Practice is an official publication of the American Academy of Allergy, Asthma & Immunology (AAAAI). It is a companion title to The Journal of Allergy and Clinical Immunology, and it aims to provide timely clinical papers, case reports, and management recommendations to clinical allergists and other physicians dealing with allergic and immunologic diseases in their practice. The mission of JACI: In Practice is to offer valid and impactful information that supports evidence-based clinical decisions in the diagnosis and management of asthma, allergies, immunologic conditions, and related diseases.
This journal publishes articles on various conditions treated by allergist-immunologists, including food allergy, respiratory disorders (such as asthma, rhinitis, nasal polyps, sinusitis, cough, ABPA, and hypersensitivity pneumonitis), drug allergy, insect sting allergy, anaphylaxis, dermatologic disorders (such as atopic dermatitis, contact dermatitis, urticaria, angioedema, and HAE), immunodeficiency, autoinflammatory syndromes, eosinophilic disorders, and mast cell disorders.
The focus of the journal is on providing cutting-edge clinical information that practitioners can use in their everyday practice or to acquire new knowledge and skills for the benefit of their patients. However, mechanistic or translational studies without immediate or near future clinical relevance, as well as animal studies, are not within the scope of the journal.